We are live on ! Find out more
JCM

Jag Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 60.59%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+60.59%
3 Year Est. Return
+229.69%
5 Year Est. Return
+291.77%
10 Year Est. Return
+2,346.89%
AUM
$489M
AUM Growth
-$46.3M
Cap. Flow
-$34.1M
Cap. Flow %
-6.98%
Top 10 Hldgs %
31.37%
Holding
108
New
15
Increased
35
Reduced
40
Closed
9

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$18.7M
2
BKNG icon
Booking.com
BKNG
+$15.5M
3
MNST icon
Monster Beverage
MNST
+$13.6M
4
GILD icon
Gilead Sciences
GILD
+$12.6M
5
NFLX icon
Netflix
NFLX
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Consumer Discretionary 16.88%
3 Industrials 16.46%
4 Communication Services 11.52%
5 Financials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
101
Monster Beverage
MNST
$92.6B
-548,430
Closed -$13.6M
NFLX icon
102
Netflix
NFLX
$309B
-895,280
Closed -$10.2M
NTES icon
103
NetEase
NTES
$82.1B
-212,340
Closed -$7.7M
REGN icon
104
Regeneron Pharmaceuticals
REGN
$79.6B
-34,373
Closed -$18.7M
CTRL
105
DELISTED
Control4 Corporation
CTRL
-12,146
Closed -$88K
KEYW
106
DELISTED
The KEYW Holding Corporation
KEYW
-29,553
Closed -$178K
BV
107
DELISTED
Bazaarvoice, Inc.
BV
-24,745
Closed -$108K

Similar funds

Jag Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Jag Capital Management held 108 positions worth $489M, down 8.7% from $535M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Jag Capital Management withdrew a net $34.1M in Q1 2016, closing 9 positions and reducing 40 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $18.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Jag Capital Management opened a new position in Eaton worth $12M.

  • Jag Capital Management's largest Q1 2016 buy was Eaton: 192,408 shares worth $12M.
  • Jag Capital Management added most to Intuitive Surgical in Q1 2016, an estimated $6.26M increase.
  • Jag Capital Management's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $12.6M.
  • Jag Capital Management fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $18.7M.
  • Jag Capital Management's ten largest holdings make up 31% of its $489M portfolio in Q1 2016.
  • Jag Capital Management opened 15 new positions and closed 9 in Q1 2016.
  • Jag Capital Management's portfolio value fell 8.7% quarter-over-quarter to $489M.

Based on Jag Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.